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to determine whether the use of MSCT co-registration will result in improved
procedural success rate.
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Background: Radiation exposure of over 7Gy at International Electric Commission
reference point [Air Kerma (AKR)] increases the risk of radiation injury. Limited data
exist on the predictors of high AKR in complex coronary chronic total occlusion (CTO)
PCI.
Methods: We reviewed the AKR in 310 consecutive CTO recanalization attempts in
303 patients. Radiation exposure was measured during the procedure.
Results: Procedural success was 73.1%. Mean fluoroscopy time was 38.4±21.4min.
Mean radiation was 5.6±3.1Gy and 328±186Gycm2. As compared to successful PCI,
failed attempts were associated with longer fluoroscopy duration (44.6±22.4min vs
36.1±20.6min; p=0.001) and higher radiation (6.2±3.3Gy vs 5.4±3.0Gy; p=0.05).
Patients with AKR above and below 7Gy are compared in the Table. Multivariable
analysis identified body surface area [OR 6.91 (95%CI 1.92, 24.83 p=0.003)], male
gender [OR 2.83 (95%CI 1.00, 8.00 p=0.0495)], calcification [OR 2.49 (95%CI 1.31,
4.71 p=0.005)] and dual injection technique [OR 2.43 (95%CI 1.32, 4.46 p=0.004)] as
independent predictors of AKR >7Gy. There were no statistically significant differences
in AKR according to CTO coronary artery or proximal vs. distal lesions.
Conclusion: Recanalization of complex CTO lesions is associated with high patient
radiation exposure to radiation. Risk factors for increased radiation include large body
surface area, male gender, calcification, and dual injection technique. When these
factors are present, increased vigilance is warranted to employ strategies that reduce
radiation exposure.
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Background: The recanalization of chronic total occlusions (CTOs) in native coronary
arteries no doubt represents one of the most technically challenging of interventional
procedures. Despite recent high success rates owing to the development of new
strategies such as the retrograde approach, complications and their management during
percutaneous coronary intervention (PCI) of CTOs have not been fully evaluated.
Methods: The aim of this study was to investigate in-hospital outcomes, including
complications, with the retrograde approach.
Results: Out of 943 cases involving 1,014 CTOs undergoing attempted recanalization
between 2005 and 2010, 278 cases (29.4%) were attempted using the retrograde
approach. The overall procedural success rate was 85% (862/1,014). CTO lesions were
most frequently located in the right coronary artery (n=166) followed by the left
anterior descending artery (n=80), and the left circumflex artery (n=33). Septal,
epicardial, and saphenous vein graft collaterals were used in 67.3%, 24.8%, and 7.9%
of cases involving the retrograde approach, respectively. Specific complications with
the retrograde approach were observed in 36 cases (14.7%) and were recovered in the
cath-lab with the exception of 1 case as shown in the table.
Conclusion: Although the complication rate during the retrograde approach was
around 15%, all cases were solved with optimal treatments. A safe procedure with
careful wire manipulation and appropriate management should be required for the
retrograde approach.
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Background: Development of a specialized chronic total coronary occlusion (CTO)
revascularization program attentive to procedural guidelines, quality oversight and
cost/resource utilization has not been described.
Methods: A single-center CTO interventional program was initiated requiring: didactic
training, on-site proctorship, determination of case appropriateness, adherence to
procedural safety guidelines and a 2-operator/case approach. Clinical and angiographic
characteristics, procedural outcomes, in-hospital clinical events and cost/resource
utilization were examined.
Results: Among 145 patients, 160 consecutive CTO revascularization procedures were
attempted between October 2009 and December 2010. Procedural and technical
characteristics included: bilateral femoral access, 90.0%; planned retrograde guidewire
placement, 37.5%; re-entry catheter, 10.0%; re-attempt, 10.6%; fluoroscopic time,
67.4±45.5 minutes; contrast volume, 403±215 mL. Average stent number and total
stent length per CTO vessel were 2.6±1.1 and 64.7±30.7, respectively. Overall CTO
success rate was 85.6% (137/160). In-hospital adverse outcomes included: death 0.6%;
emergency bypass surgery, 0.6%; tamponade, 0.6%; myocardial infarction, 1.9%.
Compared with patients undergoing non-CTO PCI, procedural and total hospital costs
per patient were significantly higher among the CTO cohort despite overall similar
contribution margins ($5,173±12,052 CTO vs $5,730±8,958 non-CTO, P=0.58).
Conclusion: Following initiation of a dedicated program with implementation of
quality and performance guidelines, complex CTO revascularization may be safely
performed with outcomes comparable to reports from established centers. Despite
higher resource utilization, CTO revascularization is associated with a positive
contribution margin similar to that of non-CTO procedures. Requirement of educational
and performance standards, mentorship from experts, consensus review for
appropriateness and provision of catheterization laboratory policies may represent a
model for program development.
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In-Stent Restenosis is Not a Benign Clinical Entity, Presenting As Acute
Coronary Syndrome In 40 % Of Cases
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Background: In-stent restenosis (ISR) following stent implantation may occur in 10-
20% of the cases according to patient and lesion complexity. We aimed to determine
the different clinical presentations of ISR in a large cohort of consecutive, non-selected
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